Traynor Capital Management, Inc. Moderna, Inc. Transaction History

Traynor Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$118.38 - $210.04 $38,236 - $67,842	323 New	323 $0
Q3 2022 Oct 20, 2022	BUY	$118.07 - $194.18 $220,318 - $362,339	1,866 New	1,866 $220,000
Q1 2022 Apr 13, 2022	SELL	$126.46 - $235.05 $742,193 - $1.38 Million	-5,869 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$225.82 - $368.51 $1.17 Million - $1.92 Million	5,198 Added 774.66%	5,869 $1.49 Million
Q3 2021 Oct 25, 2021	BUY	$221.9 - $484.47 $148,894 - $325,079	671 New	671 $258,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Traynor Capital Management, Inc. with notifications on news.